Aardvark Therapeutics
Latest round
- Series C
Last raised
- May 2024
Total raised
- $129M
Investors
- 17
About Aardvark Therapeutics
Founded in 2017 by co-founders Andreas Niethammer, and Tien Lee and based in California, US, Aardvark Therapeutics, Inc. focuses on small molecule therapeutics for obesity and rare genetic metabolic disorders. In May 2024, Aardvark Therapeutics, Inc. Aardvark Therapeutics' flagship product, ARD-101, is an oral drug designed to have low systemic exposure while providing systemic effects through gut peptide hormone secretion and gut-brain signalling. This first-in-class drug activates homeostatic pathways to treat metabolic and inflammatory diseases. Preclinical studies and initial clinical trials have demonstrated ARD-101's broad safety window and efficacy in various disease models. The company continues to advance ARD-101 through clinical development, aiming to address unmet medical needs in these therapeutic areas. In February 2025, Aardvark Therapeutics, Inc." Aardvark Therapeutics, Inc. has granted the underwriters a 30-day option to purchase up to an additional 883,200 shares of common stock as part of the listing., respectively.
Who invested in Aardvark Therapeutics
17 investors across 3 rounds
See all investors in Aardvark Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aardvark Therapeutics
Who invested in Aardvark Therapeutics?
Aardvark Therapeutics has 17 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aardvark Therapeutics raised?
Aardvark Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Aardvark Therapeutics last raise money?
Aardvark Therapeutics's most recent round on record is a Series C, in May 2024.
What does Aardvark Therapeutics do?
Founded in 2017 by co-founders Andreas Niethammer, and Tien Lee and based in California, US, Aardvark Therapeutics, Inc.
Where is Aardvark Therapeutics headquartered?
Aardvark Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Aardvark Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aardvark Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Aardvark Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.